lisocabtagene maraleucel
bms
['lymsm', 'lymphoma', 'liso-cel']
congress| #ash22 ajay major, shares results on the impact of checkpoint inhibitors on response rates, toxicity, and survival outcomes following car-t-cell relapse in pts with b-cell #lymphoma, using data from a large real-world multicenter cohort #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm